Surmodics

Vetex Medical is an Irish medical device company focused on developing innovative solutions for venous thromboembolism. The company's flagship product, the Vetex thrombectomy catheter, employs patented dynamic cage technology to effectively and efficiently remove thrombus from patients in a single session, eliminating the need for thrombolytics. Initially targeting patients with acute deep vein thrombosis (DVT) in the ilio-femoral veins, Vetex Medical aims to enhance clinical outcomes and improve the quality of life for individuals affected by conditions such as DVT, AV fistula grafts, and pulmonary embolism. The venous thrombectomy market has been historically underdeveloped, but growing clinical evidence and awareness have positioned it as a significant area of focus within the broader clot management market.

NorMedix LLC is a medical device design and development company based in Plymouth, Minnesota, specializing in ultra-thin-walled, minimally invasive catheter technologies. The company provides a comprehensive range of services, including idea generation and product innovation, technical and market feasibility assessments, prototype development, and regulatory strategies. Its product development offerings encompass design engineering, pre-clinical prototyping, project management, and human factors analysis. NorMedix also conducts verification and validation services, such as design characterization testing and clinical research, alongside manufacturing capabilities that include finished device production and supply chain management. The company’s diverse product portfolio features a variety of medical devices, including guide catheters, crossing devices, embolic protection devices, and multiple gastrointestinal systems. As of January 2016, NorMedix operates as a subsidiary of SurModics, Inc.

BioFX Laboratories specializes in the manufacturing of substrates that are essential components in diagnostic test kits. These substrates play a crucial role in detecting and signaling chemical reactions, making them integral to the effectiveness of various diagnostic tools. By focusing on the production of high-quality substrates, BioFX Laboratories supports the healthcare industry in delivering accurate and reliable diagnostic results.

Brookwood Pharmaceuticals, Inc., a leading provider of drug delivery technology primarily to the pharmaceutical industry.

InnoRx, Inc., a development stage company, develops novel therapies for the ophthalmology market. The company focuses on the development of drugs and drug delivery systems for ocular disease. Its products target age-related macular degeneration (AMD) and diabetic macular edema (DME).